IP Library Granted Patent US 7,125,874
Granted Patent B2
US 7,125,874 · App. 10/951,844 · Granted Oct 24, 2006

Optically active 5H-pyrrolo[3,4-b] pyrazine derivative, its preparation and pharmaceutical compositions containing same

Assignee: Sepracor Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,125,874
App. No.
10/951,844
Granted
Oct 24, 2006
Kind
B2
Abstract

Dextrorotatory isomer of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine, its preparation and pharmaceutical compositions containing it which are usable as tranquillisers and hypnotics.

Claims (17)

1. A method of making a dextrorotatory isomer of zopiclone, 6-(5-chloro-2-pyridyl)-5-[4-methyl-1-piperazinyl) carbonyloxy]-7-oxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine, comprising the steps of:

a) forming a first reaction mixture by mixing a solution of an optically active acid in dichloromethane to a solution of zopiclone in dichloromethane;

b) concentrating the reaction mixture to dryness under reduced pressure to form a dry salt;

c) recrystallizing the salt in acetonitrile to form a first crystallized product;

d) dissolving the crystallized product in dichloromethane with reflux;

e) adding acetonitrile to form a second reaction mixture;

f) maintaining the second reaction mixture to form a second crystallized product and recrystallizing the second crystallized product to obtain a crystallized salt;

g) dissolving the crystallized salt in water in the presence of dichloromethane to form a third reaction mixture;

h) alkalinizing the third reaction mixture to pH 11, collecting a first organic phase, extracting a remaining aqueous phase at least once with dichloromethane to obtain a second organic phase, collecting the second organic phase, and recombining the first and second organic phases;

i) washing the recombined organic phases in water, then drying over magnesium sulfate, then filtering;

j) evaporating the solvent and recrystallizing the resulting product in acetonitrile to obtain the dextrorotatory zopiclone isomer.

2. The method according to claim 1 , wherein the first crystallized product has a melting temperature of 160–165° C. and a rotatory power of [α] 20 D =83° (c=0.5; acetone).

3. The method according to claim 1 , wherein the second reaction mixture is maintained for 1 hour at 5° C.

4. The method according to claim 1 , wherein the crystallized salt has a melting temperature of 160–165° C. and a rotary power of [α] 20 D =102° (c=0.5; acetone).

5. The method according to claim 1 , wherein the alkalinizing of the third reaction mixture is achieved by the slow addition of a basic aqueous solution.

6. The method according to claim 1 , wherein the dextrorotatory zopiclone isomer has a melting temperature of 206.5° C. and [α] 20 D =135°±3° (c=1.0; acetone).

7. The method according to claim 1 , wherein the optically active acid is D(+)-O,O′-dibenzoyltartaric acid.

Assignments (2)
CHANGE OF NAME Recorded Dec 9, 2010
From: SEPRACOR INC.
To: SUNOVION PHARMACEUTICALS INC.
Reel/Frame 025484/0050 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2009
From: COTREL, CLAUDE; ROUSSEL, GERARD
To: SEPRACOR INC.
Reel/Frame 022343/0048 →
Priority Claims (1)
FR 91 00490 · Jan 17, 1991 · national
Continuity (10)
Continuation 1020051000 · Jul 23, 2002
Division 0972243800 · Nov 28, 2000
Continuation 0912465100 · Jul 29, 1998
Continuation 0849394600 · Jun 23, 1995
Continuation 0834279400 · Nov 21, 1994
Continuation 0823231300 · Apr 25, 1994
Continuation 0810986300 · Aug 20, 1993
Continuation 0803419900 · Mar 19, 1993
Continuation 0782166200 · Jan 16, 1992
Related Publication 20050043311A1 · Feb 24, 2005